temozolomide has been researched along with Astroblastoma in 31 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Genotyping of putative determinants of temozolomide (TMZ)-induced life-threatening bone marrow suppression was performed in two patients with glioma treated with adjuvant TMZ and radiation therapy." | 3.77 | Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. ( Berg, A; Kolesar, J; Mehta, M; Petrich, RJ; Steen, P; Sylvester, RK; Tate, JM, 2011) |
| "Because of the diffuse nature of gliomatosis cerebri (GC), surgery is not suitable, and large field radiotherapy carries the risk of severe toxicity." | 2.71 | Initial chemotherapy in gliomatosis cerebri. ( Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S, 2004) |
| "The optimal therapy for gliomatosis cerebri is unclear, and the rate of response to chemotherapy is not known." | 2.71 | Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. ( Gomori, JM; Levin, N; Siegal, T, 2004) |
| "Dysembryoplastic neuroepithelial tumors (DNETs) are low-grade neuroglial tumors that are traditionally considered to be benign hamartoma-like mass lesions." | 1.43 | Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor. ( Fenstermaker, RA; Mechtler, LL; Morr, S; Prasad, D; Qiu, J, 2016) |
| "Clinical presentation of gliomatosis cerebri is variable and depends on the degree, extent, and location of cortical involvement." | 1.39 | Bilateral ptosis as initial presentation of gliomatosis cerebri: case report. ( Braca, J; Kovanda, T; Prabhu, V, 2013) |
| "Gliomatosis cerebri is a rare primary cerebral tumour entity characterized by diffuse infiltrative growth patterns representing a WHO grade III malignancy." | 1.35 | First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity. ( Brockmann, MA; Hermes, P; Kohlhof, P; Neumaier-Probst, E; Schmieder, K; Seiz, M; Tuettenberg, J; Vajkoczy, P; VON Deimling, A, 2009) |
| "Astroblastoma is a historically traded microscopic diagnosis to denote a rare neuroepithelial tumor of uncertain nosology, involving a distinctive pattern of pseudorosette arrangement of neoplastic cells." | 1.35 | Astroblastoma with rhabdoid features and favorable long-term outcome: report of a case with a 12-year follow-up. ( El-Koussy, M; Fathi, AR; Kappeler, A; Mariani, L; Novoa, E; Vajtai, I, 2008) |
| "Temozolomide has shown antineoplastic activity against malignant gliomas and more recently was beneficial in one patient with gliomatosis cerebri." | 1.32 | Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration. ( Ambrosetto, P; Barbiroli, B; Cortelli, P; Crinò, L; Franceschi, E; Lodi, R; Setola, E; Tonon, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 14 (45.16) | 24.3611 |
| 2020's | 5 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Gonda, T | 1 |
| Wakabayashi, K | 1 |
| Haraguchi, K | 1 |
| Arai, Y | 1 |
| Oyama, H | 1 |
| Sarper, B | 1 |
| Yaprak Bayrak, B | 1 |
| Halis, H | 1 |
| Alparslan, B | 1 |
| Yeni Bayraktar, H | 1 |
| Kuo, C | 1 |
| Foon, D | 1 |
| Waters, K | 1 |
| Cheung, C | 1 |
| Margol, AS | 1 |
| Nakano, Y | 1 |
| Yamasaki, K | 2 |
| Satomi, K | 1 |
| Fukushima, H | 1 |
| Okuhiro, Y | 1 |
| Okada, K | 1 |
| Osugi, Y | 1 |
| Sakamoto, H | 1 |
| Inoue, T | 2 |
| Yoshida, A | 1 |
| Ichimura, K | 1 |
| Hara, J | 1 |
| Bale, TA | 1 |
| Sait, SF | 1 |
| Benhamida, J | 1 |
| Ptashkin, R | 1 |
| Haque, S | 1 |
| Villafania, L | 1 |
| Sill, M | 1 |
| Sadowska, J | 1 |
| Akhtar, RB | 1 |
| Liechty, B | 1 |
| Juthani, R | 1 |
| Ladanyi, M | 1 |
| Fowkes, M | 1 |
| Karajannis, MA | 1 |
| Rosenblum, MK | 1 |
| Carroll, KT | 1 |
| Hirshman, B | 1 |
| Ali, MA | 1 |
| Alattar, AA | 1 |
| Brandel, MG | 1 |
| Lochte, B | 1 |
| Lanman, T | 1 |
| Carter, B | 1 |
| Chen, CC | 1 |
| Zhang, J | 1 |
| Xiao, X | 1 |
| Zhu, J | 2 |
| Gao, Z | 1 |
| Lai, X | 2 |
| Zhu, X | 2 |
| Mao, G | 1 |
| Autran, D | 1 |
| Barrie, M | 1 |
| Matta, M | 1 |
| Monserrat, C | 1 |
| Campello, C | 1 |
| Petrirena, G | 1 |
| Boucard, C | 1 |
| Padovani, L | 1 |
| Loundou, A | 1 |
| Appay, R | 1 |
| Graillon, T | 1 |
| Dufour, H | 1 |
| Figarella-Branger, D | 1 |
| Chinot, O | 2 |
| Tabouret, E | 1 |
| Kovanda, T | 1 |
| Braca, J | 1 |
| Prabhu, V | 1 |
| Yokogami, K | 1 |
| Ohta, H | 1 |
| Yamashita, S | 1 |
| Uehara, H | 1 |
| Sato, Y | 1 |
| Takeshima, H | 1 |
| Bertero, L | 1 |
| Cassoni, P | 1 |
| Rudà, R | 1 |
| Chen, Z | 1 |
| Song, S | 1 |
| Morr, S | 1 |
| Qiu, J | 1 |
| Prasad, D | 1 |
| Mechtler, LL | 1 |
| Fenstermaker, RA | 1 |
| Jicha, GA | 1 |
| Glantz, J | 1 |
| Clarke, MJ | 1 |
| Lehwald, LM | 1 |
| Russo, DP | 1 |
| Giannini, C | 1 |
| Wald, JT | 1 |
| Uhm, J | 1 |
| Kumar, N | 1 |
| Aksamit, AJ | 1 |
| Wetmore, CJ | 1 |
| Seiz, M | 1 |
| Kohlhof, P | 1 |
| Brockmann, MA | 1 |
| Neumaier-Probst, E | 1 |
| Hermes, P | 1 |
| VON Deimling, A | 1 |
| Vajkoczy, P | 1 |
| Schmieder, K | 1 |
| Tuettenberg, J | 1 |
| Kong, DS | 1 |
| Kim, ST | 1 |
| Lee, JI | 1 |
| Suh, YL | 1 |
| Lim, DH | 1 |
| Kim, WS | 1 |
| Kwon, KH | 1 |
| Park, K | 1 |
| Kim, JH | 1 |
| Nam, DH | 1 |
| Sylvester, RK | 1 |
| Steen, P | 1 |
| Tate, JM | 1 |
| Mehta, M | 1 |
| Petrich, RJ | 1 |
| Berg, A | 1 |
| Kolesar, J | 1 |
| Kumabe, T | 1 |
| Kanamori, M | 1 |
| Sonoda, Y | 1 |
| Watanabe, M | 1 |
| Tominaga, T | 1 |
| Chadarévian, JP | 1 |
| Legido, A | 1 |
| Halligan, GE | 1 |
| Faerber, EN | 1 |
| Piatt, JH | 1 |
| Morrissette, JD | 1 |
| Ara, J | 1 |
| Grant, ML | 1 |
| Katsetos, CD | 1 |
| Hansen, N | 1 |
| Wittig, A | 1 |
| Hense, J | 1 |
| Kastrup, O | 1 |
| Gizewski, ER | 1 |
| Van de Nes, JA | 1 |
| Mattox, AK | 1 |
| Lark, AL | 1 |
| Adamson, DC | 1 |
| Hargrave, D | 1 |
| Bouffet, E | 2 |
| Gammon, J | 1 |
| Becker, L | 1 |
| Rutka, J | 1 |
| Baruchel, S | 1 |
| Lodi, R | 1 |
| Setola, E | 1 |
| Tonon, C | 1 |
| Ambrosetto, P | 1 |
| Franceschi, E | 1 |
| Crinò, L | 1 |
| Barbiroli, B | 1 |
| Cortelli, P | 1 |
| Chamberlain, MC | 1 |
| Sanson, M | 2 |
| Cartalat-Carel, S | 1 |
| Taillibert, S | 1 |
| Napolitano, M | 1 |
| Djafari, L | 1 |
| Cougnard, J | 1 |
| Gervais, H | 1 |
| Laigle, F | 1 |
| Carpentier, A | 1 |
| Mokhtari, K | 2 |
| Taillandier, L | 1 |
| Duffau, H | 1 |
| Honnorat, J | 1 |
| Hoang-Xuan, K | 2 |
| Delattre, JY | 2 |
| Levin, N | 1 |
| Gomori, JM | 1 |
| Siegal, T | 1 |
| Piccirilli, M | 1 |
| Landi, A | 1 |
| Salvati, M | 1 |
| Terasaki, M | 1 |
| Katsuki, H | 1 |
| Fukushima, S | 1 |
| Shigemori, M | 1 |
| Fathi, AR | 1 |
| Novoa, E | 1 |
| El-Koussy, M | 1 |
| Kappeler, A | 1 |
| Mariani, L | 1 |
| Vajtai, I | 1 |
| Kaloshi, G | 1 |
| Everhard, S | 1 |
| Laigle-Donadey, F | 1 |
| Marie, Y | 1 |
| Navarro, S | 1 |
| Idbaih, A | 1 |
| Ducray, F | 1 |
| Thillet, J | 1 |
| Benjelloun, A | 1 |
| Delavelle, J | 1 |
| Lazeyras, F | 1 |
| Dietrich, PY | 1 |
2 reviews available for temozolomide and Astroblastoma
| Article | Year |
|---|---|
Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellum; Child, Preschool; Dacarbazine; | 2012 |
Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Child, Preschool | 2012 |
5 trials available for temozolomide and Astroblastoma
| Article | Year |
|---|---|
Impact of adjuvant chemotherapy for gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine | 2010 |
Initial chemotherapy in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combin | 2004 |
Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Combined Modalit | 2004 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; | 2008 |
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Chromosome Mapping; C | 2008 |
24 other studies available for temozolomide and Astroblastoma
| Article | Year |
|---|---|
[Primary leptomeningeal gliomatosis treated with temozolomide: a case report].
Topics: Adult; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meninges; Neoplasms, Neuroepit | 2021 |
Malignant Astroblastoma
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bevacizumab; Headache; Huma | 2020 |
Central diabetes insipidus: A rare unreported side effect of temozolomide in pediatrics.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Diabetes Insipidus, Neurogenic; Humans; M | 2020 |
A case of pediatric gliomatosis cerebri harboring H3F3A K27 mutation.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Female; Histones; Humans; Magnetic Resona | 2020 |
Malignant transformation of a polymorphous low grade neuroepithelial tumor of the young (PLNTY).
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Edema; Brain Neoplasms; Chemoradiotherapy; Fema | 2021 |
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Brain N | 2017 |
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbaz | 2018 |
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Combined M | 2019 |
Bilateral ptosis as initial presentation of gliomatosis cerebri: case report.
Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Blepharoptosis; Brain Neoplasms; Chemoradiothera | 2013 |
Case of primary diffuse leptomeningeal gliomatosis.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Fat | 2014 |
Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain; Brain Abscess; Brain Neoplasms; Dacarbazine; Humans; | 2015 |
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Dacarbazine; DNA; Drug | 2016 |
Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioma; Humans; Neop | 2016 |
Primary diffuse leptomeningeal gliomatosis.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain; Dacarbazine; Diagnosis, Differential; Humans; | 2009 |
First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Proliferation; Cyclooxy | 2009 |
Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients.
Topics: Adult; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding | 2011 |
Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biopsy; Brain Neo | 2010 |
Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.
Topics: Antineoplastic Agents, Alkylating; Chemoradiotherapy; Dacarbazine; Humans; Male; Meningeal Neoplasms | 2011 |
Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Leukemi | 2003 |
Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
Topics: Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Humans; Magnetic Resonance I | 2003 |
Gliomatosis cerebri: better definition, better treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocyt | 2004 |
Gliomatosis cerebri treatment in 11 elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined M | 2006 |
Astroblastoma with rhabdoid features and favorable long-term outcome: report of a case with a 12-year follow-up.
Topics: Antibodies, Antinuclear; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; | 2008 |
Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Humans; Magnetic Reso | 2001 |